These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 15454137)

  • 21. [Surgical therapy of gastrinoma with associated Zollinger-Ellison syndrome].
    Schröder W; Hölscher AH; Beckurts KT; Schusdziarra V; Höfler H; Siewert JR
    Z Gastroenterol; 1996 Aug; 34(8):465-72. PubMed ID: 8967120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia.
    Sjöblom SM; Sipponen P; Miettinen M; Karonen SL; Jrvinen HJ
    Endoscopy; 1988 Mar; 20(2):52-6. PubMed ID: 3383791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects of ECL-cell abnormalities.
    Hirschowitz BI
    Yale J Biol Med; 1998; 71(3-4):303-10. PubMed ID: 10461361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gastric carcinoid tumours. Is there a place for antrectomy?].
    Guillem P
    Ann Chir; 2005 Jun; 130(5):323-6. PubMed ID: 15890310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric carcinoids with minimal or no macroscopic lesion in patients with pernicious anemia.
    Lehtola J; Karttunen T; Krekelä I; Niemelä S; Räsänen O
    Hepatogastroenterology; 1985 Apr; 32(2):72-6. PubMed ID: 4007765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine tumours of the stomach.
    Delle Fave G; Capurso G; Milione M; Panzuto F
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):659-73. PubMed ID: 16253892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
    Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
    Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors.
    Dakin GF; Warner RR; Pomp A; Salky B; Inabnet WB
    J Surg Oncol; 2006 Apr; 93(5):368-72. PubMed ID: 16550587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carcinoid tumor of the stomach--aspects of surgical therapy].
    Storck M; Jauch KW; Wiebeke B; Denecke H
    Chirurg; 1991 Apr; 62(4):284-8. PubMed ID: 1860352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple gastric carcinoid tumours in a patient with pernicious anaemia: endoscopic removal or gastric resection?
    McAleese P; Moorehead J
    Eur J Surg; 1994 Apr; 160(4):243-6. PubMed ID: 8049316
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome.
    Hirschowitz BI
    Yale J Biol Med; 1992; 65(6):659-76; discussion 689-92. PubMed ID: 1341070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
    Hirschowitz BI; Worthington J; Mohnen J; Haber M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple gastric carcinoids, atrophic gastritis, hypergastrinemia: a confirmed association (a new case)].
    González Martín JA; De Miguel R; Martínez Montiel MP; Pérez Sola A; Razquin J; Calvo A; Saiz F
    Rev Esp Enferm Apar Dig; 1989 Aug; 76(2):161-4. PubMed ID: 2682832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
    Feurle GE
    Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypergastrinemia and recurrent type 1 gastric carcinoid in a young Indian male: necessity for antrectomy?
    Senadhi V; Jani N
    World J Gastroenterol; 2011 Sep; 17(35):4052-4. PubMed ID: 22046097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pernicious anemia and gastric carcinoid tumor: case report and review.
    Sculco D; Bilgrami S
    Am J Gastroenterol; 1997 Aug; 92(8):1378-80. PubMed ID: 9260813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
    Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
    World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total gastrectomy for type 1 gastric carcinoid: an unusual surgical indication?
    Clemente G; Sarno G; Giordano M; De Rose AM; Giovannini I; Vecchio FM; Nuzzo G
    Minerva Chir; 2007 Oct; 62(5):421-4. PubMed ID: 17947953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
    Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
    Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.